Pharmacological prevention of intimal hyperplasia: A state-of-the-art review
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference115 articles.
1. A case of heterozygous familial hypercholesterolemia requiring strict low-density lipoprotein cholesterol management with proprotein convertase subtilisin/kexin 9 inhibitor after coronary artery bypass grafting;Abe;Journal of Cardiology Cases,2021
2. Nitric oxide deficit drives intimal hyperplasia in mouse models of hypertension;Allagnat;European Journal of Vascular and Endovascular Surgery,2016
3. The antioxidant effect of tannic acid on the in vitro copper-mediated formation of free radicals;Andrade;Archives of Biochemistry and Biophysics,2005
4. Adventitial injection delivery of nano-encapsulated sirolimus (Nanolimus) to injury-induced porcine femoral vessels to reduce luminal restenosis;Ang;Journal of Controlled Release,2020
5. Combinatorial therapy of sirolimus and heparin by nanocarrier inhibits restenosis after balloon angioplasty ex vivo;Betala;Nanomedicine,2020
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials;Frontiers in Pharmacology;2024-01-05
2. Effect of sequential release of sirolimus and rosuvastatin using silk fibroin microneedle to prevent intimal hyperplasia;Biomedicine & Pharmacotherapy;2023-12
3. Macrophage‐Biomimetic Nanoplatform‐Based Therapy for Inflammation‐Associated Diseases;Small Methods;2023-11-30
4. IL-13 neutralization attenuates carotid artery intimal hyperplasia and increases endothelial cell migration via modulating the JAK-1/STAT-3 signaling pathway;Cell Adhesion & Migration;2023-10-09
5. Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation;2023-10-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3